Slide
Centre Interdisciplinaire
de Recherche et d’Innovation
en Cybersécurité et Société
de Recherche et d’Innovation
en Cybersécurité et Société
1.
Bogie, B. J. M.; Noël, C.; Gu, F.; Nadeau, S.; Shvetz, C.; Khan, H.; Rivard, M. -C.; Bouchard, S.; Lepage, M.; Guimond, S.
Using virtual reality to improve verbal episodic memory in schizophrenia: A proof-of-concept trial Article de journal
Dans: Schizophrenia Research: Cognition, vol. 36, 2024, ISSN: 22150013 (ISSN), (Publisher: Elsevier Inc.).
Résumé | Liens | BibTeX | Étiquettes: adult, article, clinical article, clinical assessment, Cognitive remediation therapy, cybersickness, disease severity, dizziness, Ecological treatment, Episodic memory, exclusion VR criteria questionnaire, feasibility study, female, Hopkins verbal learning test, human, male, mini international neuropsychiatric interview, nausea, outcome assessment, Positive and Negative Syndrome Scale, Proof of concept, questionnaire, randomized controlled trial, schizophrenia, scoring system, Semantic encoding, Semantics, task performance, training, Verbal memory, virtual reality, vr experience questionnaire
@article{bogie_using_2024,
title = {Using virtual reality to improve verbal episodic memory in schizophrenia: A proof-of-concept trial},
author = {B. J. M. Bogie and C. Noël and F. Gu and S. Nadeau and C. Shvetz and H. Khan and M. -C. Rivard and S. Bouchard and M. Lepage and S. Guimond},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85186986986&doi=10.1016%2fj.scog.2024.100305&partnerID=40&md5=a15c598b45b8f44a40b25fe5fd078a06},
doi = {10.1016/j.scog.2024.100305},
issn = {22150013 (ISSN)},
year = {2024},
date = {2024-01-01},
journal = {Schizophrenia Research: Cognition},
volume = {36},
abstract = {Background: Schizophrenia is associated with impairments in verbal episodic memory. Strategy for Semantic Association Memory (SESAME) training represents a promising cognitive remediation program to improve verbal episodic memory. Virtual reality (VR) may be a novel tool to increase the ecological validity and transfer of learned skills of traditional cognitive remediation programs. The present proof-of-concept study aimed to assess the feasibility, acceptability, and preliminary efficacy of a VR-based cognitive remediation module inspired by SESAME principles to improve the use of verbal episodic memory strategies in schizophrenia. Methods: Thirty individuals with schizophrenia/schizoaffective disorder completed this study. Participants were randomized to either a VR-based verbal episodic memory training condition inspired by SESAME principles (intervention group) or an active control condition (control group). In the training condition, a coach taught semantic encoding strategies (active rehearsal and semantic clustering) to help participants remember restaurant orders in VR. In the active control condition, participants completed visuospatial puzzles in VR. Attrition rate, participant experience ratings, and cybersickness questionnaires were used to assess feasibility and acceptability. Trial 1 of the Hopkins Verbal Learning Test – Revised was administered pre- and post-intervention to assess preliminary efficacy. Results: Feasibility was demonstrated by a low attrition rate (5.88 %), and acceptability was demonstrated by limited cybersickness and high levels of enjoyment. Although the increase in the number of semantic clusters used following the module did not reach conventional levels of statistical significance in the intervention group, it demonstrated a notable trend with a medium effect size (t = 1.48},
note = {Publisher: Elsevier Inc.},
keywords = {adult, article, clinical article, clinical assessment, Cognitive remediation therapy, cybersickness, disease severity, dizziness, Ecological treatment, Episodic memory, exclusion VR criteria questionnaire, feasibility study, female, Hopkins verbal learning test, human, male, mini international neuropsychiatric interview, nausea, outcome assessment, Positive and Negative Syndrome Scale, Proof of concept, questionnaire, randomized controlled trial, schizophrenia, scoring system, Semantic encoding, Semantics, task performance, training, Verbal memory, virtual reality, vr experience questionnaire},
pubstate = {published},
tppubtype = {article}
}
Background: Schizophrenia is associated with impairments in verbal episodic memory. Strategy for Semantic Association Memory (SESAME) training represents a promising cognitive remediation program to improve verbal episodic memory. Virtual reality (VR) may be a novel tool to increase the ecological validity and transfer of learned skills of traditional cognitive remediation programs. The present proof-of-concept study aimed to assess the feasibility, acceptability, and preliminary efficacy of a VR-based cognitive remediation module inspired by SESAME principles to improve the use of verbal episodic memory strategies in schizophrenia. Methods: Thirty individuals with schizophrenia/schizoaffective disorder completed this study. Participants were randomized to either a VR-based verbal episodic memory training condition inspired by SESAME principles (intervention group) or an active control condition (control group). In the training condition, a coach taught semantic encoding strategies (active rehearsal and semantic clustering) to help participants remember restaurant orders in VR. In the active control condition, participants completed visuospatial puzzles in VR. Attrition rate, participant experience ratings, and cybersickness questionnaires were used to assess feasibility and acceptability. Trial 1 of the Hopkins Verbal Learning Test – Revised was administered pre- and post-intervention to assess preliminary efficacy. Results: Feasibility was demonstrated by a low attrition rate (5.88 %), and acceptability was demonstrated by limited cybersickness and high levels of enjoyment. Although the increase in the number of semantic clusters used following the module did not reach conventional levels of statistical significance in the intervention group, it demonstrated a notable trend with a medium effect size (t = 1.48
2.
Bouchard, S.; Berthiaume, M.; Robillard, G.; Forget, H.; Daudelin-Peltier, C.; Renaud, P.; Blais, C.; Fiset, D.
Arguing in Favor of Revising the Simulator Sickness Questionnaire Factor Structure When Assessing Side Effects Induced by Immersions in Virtual Reality Article de journal
Dans: Frontiers in Psychiatry, vol. 12, 2021, ISSN: 16640640 (ISSN), (Publisher: Frontiers Media S.A.).
Résumé | Liens | BibTeX | Étiquettes: adult, Anxiety, Anxiety disorder, article, attention disturbance, blurred vision, confounding variable, controlled study, correlational study, cybersickness, disease association, dizziness, eye movement disorder, fatigue, female, headache, human, hypersalivation, immersion, major clinical study, male, nausea, scoring system, simulator sickness, Simulator Sickness Questionnaire, State Trait Anxiety Inventory, stomach disease, sweat gland disease, sweating, Trier Stress Social Test, vertigo, virtual reality
@article{bouchard_arguing_2021,
title = {Arguing in Favor of Revising the Simulator Sickness Questionnaire Factor Structure When Assessing Side Effects Induced by Immersions in Virtual Reality},
author = {S. Bouchard and M. Berthiaume and G. Robillard and H. Forget and C. Daudelin-Peltier and P. Renaud and C. Blais and D. Fiset},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119514106&doi=10.3389%2ffpsyt.2021.739742&partnerID=40&md5=83c5198937636133854ac31ad7f749a5},
doi = {10.3389/fpsyt.2021.739742},
issn = {16640640 (ISSN)},
year = {2021},
date = {2021-01-01},
journal = {Frontiers in Psychiatry},
volume = {12},
abstract = {Two issues are increasingly of interest in the scientific literature regarding unwanted virtual reality (VR) induced side effects: (1) whether the latent structure of the Simulator Sickness Questionnaire (SSQ) is comprised of two or three factors, and (2) if the SSQ measures symptoms of anxiety that can be misattributed to unwanted negative side effects induced by immersions in VR. Study 1 was conducted with a sample of 876 participants. A confirmatory factor analysis clearly supported a two-factor model composed of nausea and oculomotor symptoms instead of the 3-factor structure observed in simulators. To tease-out symptoms of anxiety from unwanted negative side effects induced by immersions in VR, Study 2 was conducted with 88 participants who were administered the Trier Stress Social Test in groups without being immersed in VR. A Spearman correlation showed that 11 out of 16 side effects correlated significantly with anxiety. A factor analysis revealed that items measuring general discomfort, difficulty concentrating, sweating, nausea, and vertigo loaded significantly on the anxiety factor comprised of items from the State-Trait Anxiety Inventory. Finally, a multiple regression indicated that the items measuring general discomfort and difficulty concentrating significantly predicted increases in anxiety. The overall results support the notion that side effects associated with immersions in VR consist mostly of a nausea and an oculomotor latent structure and that a few items are confounding anxiety and cybersickness. The data support the suggestion to revise the scoring procedures of the Simulator Sickness Questionnaire when using this instrument with immersions in VR. Copyright © 2021 Bouchard, Berthiaume, Robillard, Forget, Daudelin-Peltier, Renaud, Blais and Fiset.},
note = {Publisher: Frontiers Media S.A.},
keywords = {adult, Anxiety, Anxiety disorder, article, attention disturbance, blurred vision, confounding variable, controlled study, correlational study, cybersickness, disease association, dizziness, eye movement disorder, fatigue, female, headache, human, hypersalivation, immersion, major clinical study, male, nausea, scoring system, simulator sickness, Simulator Sickness Questionnaire, State Trait Anxiety Inventory, stomach disease, sweat gland disease, sweating, Trier Stress Social Test, vertigo, virtual reality},
pubstate = {published},
tppubtype = {article}
}
Two issues are increasingly of interest in the scientific literature regarding unwanted virtual reality (VR) induced side effects: (1) whether the latent structure of the Simulator Sickness Questionnaire (SSQ) is comprised of two or three factors, and (2) if the SSQ measures symptoms of anxiety that can be misattributed to unwanted negative side effects induced by immersions in VR. Study 1 was conducted with a sample of 876 participants. A confirmatory factor analysis clearly supported a two-factor model composed of nausea and oculomotor symptoms instead of the 3-factor structure observed in simulators. To tease-out symptoms of anxiety from unwanted negative side effects induced by immersions in VR, Study 2 was conducted with 88 participants who were administered the Trier Stress Social Test in groups without being immersed in VR. A Spearman correlation showed that 11 out of 16 side effects correlated significantly with anxiety. A factor analysis revealed that items measuring general discomfort, difficulty concentrating, sweating, nausea, and vertigo loaded significantly on the anxiety factor comprised of items from the State-Trait Anxiety Inventory. Finally, a multiple regression indicated that the items measuring general discomfort and difficulty concentrating significantly predicted increases in anxiety. The overall results support the notion that side effects associated with immersions in VR consist mostly of a nausea and an oculomotor latent structure and that a few items are confounding anxiety and cybersickness. The data support the suggestion to revise the scoring procedures of the Simulator Sickness Questionnaire when using this instrument with immersions in VR. Copyright © 2021 Bouchard, Berthiaume, Robillard, Forget, Daudelin-Peltier, Renaud, Blais and Fiset.
3.
Bouchard, S.; St-Jacques, J.; Renaud, P.; Wiederhold, B. K.
Side effects of immersions in virtual reality for people suffering from anxiety disorders Article de journal
Dans: Journal of Cyber Therapy and Rehabilitation, vol. 2, no 2, p. 127–137, 2009, ISSN: 17849934.
Résumé | Liens | BibTeX | Étiquettes: Anxiety disorder, article, body movement, clinical feature, cybersickness, disorientation, Fear, human, intermethod comparison, medical assessment, motion sickness, named inventories, nausea, patient safety, phobia, questionnaires and rating scales, Simulator Sickness Questionnaire, virtual reality
@article{bouchard_side_2009,
title = {Side effects of immersions in virtual reality for people suffering from anxiety disorders},
author = {S. Bouchard and J. St-Jacques and P. Renaud and B. K. Wiederhold},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951669278&partnerID=40&md5=95f1086038ef0b2259780162f8c2082f},
issn = {17849934},
year = {2009},
date = {2009-01-01},
journal = {Journal of Cyber Therapy and Rehabilitation},
volume = {2},
number = {2},
pages = {127–137},
abstract = {Side effects caused by immersions in virtual reality (VR) have been documented in experimental studies and with healthy people. With the growing interest of VR applications to assess and treat mental disorders, empirical information on side effects in clinical populations is needed. Three studies were conducted to: (a) describe symptoms and scores on the Simulator Sickness Questionnaire (SSQ) in a sample of 157 adults immersed in VR to treat their phobias, (b) compare exposure treatments involving more or less actions and motions (N = 34); and (c) document the usefulness of assessing symptoms prior to the immersion in VR and following up 26 phobic patients 24 hours post-immersion. Overall, results show that most participants experienced slight side effects, symptoms were strong even before immersion in VR and there are no reasons to be generally concerned with health and safety issues within 24 hours after therapy sessions. Exposure in VR to treat fear of flying was associated with fewer side effects than for other anxiety disorders. The scores on the SSQ were much higher than in studies conducted with non-clinical samples, raising several research questions. Side effects should not be a source of worries but they must be closely monitored and systematically reported in outcome studies. © Virtual Reality Medical Institute.},
keywords = {Anxiety disorder, article, body movement, clinical feature, cybersickness, disorientation, Fear, human, intermethod comparison, medical assessment, motion sickness, named inventories, nausea, patient safety, phobia, questionnaires and rating scales, Simulator Sickness Questionnaire, virtual reality},
pubstate = {published},
tppubtype = {article}
}
Side effects caused by immersions in virtual reality (VR) have been documented in experimental studies and with healthy people. With the growing interest of VR applications to assess and treat mental disorders, empirical information on side effects in clinical populations is needed. Three studies were conducted to: (a) describe symptoms and scores on the Simulator Sickness Questionnaire (SSQ) in a sample of 157 adults immersed in VR to treat their phobias, (b) compare exposure treatments involving more or less actions and motions (N = 34); and (c) document the usefulness of assessing symptoms prior to the immersion in VR and following up 26 phobic patients 24 hours post-immersion. Overall, results show that most participants experienced slight side effects, symptoms were strong even before immersion in VR and there are no reasons to be generally concerned with health and safety issues within 24 hours after therapy sessions. Exposure in VR to treat fear of flying was associated with fewer side effects than for other anxiety disorders. The scores on the SSQ were much higher than in studies conducted with non-clinical samples, raising several research questions. Side effects should not be a source of worries but they must be closely monitored and systematically reported in outcome studies. © Virtual Reality Medical Institute.